Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5902957 | 6746242 | F | 5902957-6 | 20080826 | 20080930 | EXP | PHHY2008IE17856 | NOVARTIS PHARMACEUTICALS CORP. | F | Y | 20080930 | CN | IRELAND |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5902957 | 1010518939 | PS | DIOVAN | 1 | ORAL | 80 MG, QD | 021283 | ||||
| 5902957 | 1010518940 | SS | DIOVAN | 1 | 160 MG, QD | 021283 | |||||
| 5902957 | 1010518941 | SS | DIOVAN | 1 | 160 3/4 TAB | 021283 | |||||
| 5902957 | 1010518942 | C | NU-SEALS ASPIRIN | 2 | ORAL | 75 MG/DAY | |||||
| 5902957 | 1010518943 | C | ACETAMINOPHEN | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5902957 | 1010518939 | HYPERTENSION |
Outcome of event
| no results found |
Reactions reported
| Event ID | PT |
|---|---|
| 5902957 | DIZZINESS |
| 5902957 | FEELING ABNORMAL |
| 5902957 | INSOMNIA |
| 5902957 | PAIN |
| 5902957 | SENSORY DISTURBANCE |
| 5902957 | TENSION HEADACHE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5902957 | 1010518939 | 20080301 |